A Phase 4 Observational, Real-World Study of 20-valent Pneumococcal Conjugate Vaccine Effectiveness Against Vaccine-Type Invasive Pneumococcal Disease in Adults Aged 65 years and above First published 27/03/2024 Last updated 04/07/2025 EU PAS number:EUPAS1000000007 Study Planned